MPD: Project measures / variables set: GMC16 amylase

Project measures / variables set: GMC16 amylase

ID, description, units	MPD:56534 amylase alpha-amylase (plasma) [IU/L]
Measures	• age 16-17wks • 20-21wks
Data set, strains	GMC16 inbred w/CC8 8 strains sex: both
Procedure	metabolic panel
Comparison	multiple cohorts measured at two age timepoints
Ontology mappings	VT:0010475 blood amylase amount MA:0002501 plasma MP:0008804 abnormal circulating amylase level

Values Means Δ Means Z-scores

Graph Type Points Bars

Dimensions Width: × Height: px

Plot Options Hide Error Bars Strains on X-axis

Data Type:

Dimensions Height: px

Toggle Series

Plot Options Show Standard Error Show Point Labels Flip Axes Shared Tooltip Connect Gaps

Advanced Plot Options

Separate Plot Factor(s)

Legend Factor(s)

X-Axis Factor(s)

Include/Exclude Factor Values

GMC16 - alpha-amylase (plasma)

ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary

Factor	DF	Sum of squares	Mean sum of squares	F value	p-value (Pr>F)
age	1	802099.8295	802099.8295	73.9149	< 0.0001
sex	1	216520.9011	216520.9011	19.9528	< 0.0001
strain	4	2212667.2541	553166.8135	50.9753	< 0.0001
age:sex	1	835.071	835.071	0.077	0.7819
age:strain	4	82881.7457	20720.4364	1.9094	0.1128
sex:strain	4	239165.6159	59791.404	5.5099	0.0004
age:sex:strain	4	80786.9712	20196.7428	1.8612	0.1212
Residuals	128	1389012.3825	10851.6592

Q-Q normality assessment based on residuals

INDIVIDUAL MEASURES

Project	ID		Treatment	Measure / Variable Description	Panel	Strains tested	Sex	Age
GMC16	56534	metabolic panel	(none)	alpha-amylase (plasma) [IU/L] at age 16-17wks amylase_17	inbred w/CC8	7	both	16-17wks
GMC16	56535	metabolic panel	(none)	alpha-amylase (plasma) [IU/L] at age 20-21wks amylase_21	inbred w/CC8	8	both	20-21wks